Charles Schwab Investment Management Inc Madrigal Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 147,970 shares of MDGL stock, worth $47.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
147,970
Previous 138,314
6.98%
Holding current value
$47.1 Million
Previous $38.8 Million
18.96%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding MDGL
# of Institutions
298Shares Held
22MCall Options Held
819KPut Options Held
640K-
Janus Henderson Group PLC London, X02.48MShares$789 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$650 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$646 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$635 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$629 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.45B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...